Peter Coutlakis, MD
Rheumatology · Richmond, VANPI 1528064482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 601 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations.
Across 601 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- Johnson & Johnson$2K
- Pfizer$922
- Novartis$881
- UCB, Inc.$819
- plus $4K from 28 others
What the payments were for
- Food & beverage$11,41898%
- Education$2302%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 89 | $1,817 |
| AbbVie | 90 | $1,607 |
| Johnson & Johnson | 93 | $1,588 |
| Pfizer | 57 | $922 |
| Novartis | 40 | $881 |
| UCB, Inc. | 40 | $819 |
| Lilly USA, LLC | 33 | $696 |
| E.r. Squibb & Sons, L.L.C. | 26 | $470 |
| Mallinckrodt Hospital Products Inc. | 20 | $461 |
| GSK | 22 | $335 |
| AstraZeneca(2 entities) | 15 | $309 |
| Radius Health, Inc. | 10 | $290 |
| Genentech USA, Inc. | 11 | $209 |
| ANI Pharmaceuticals, Inc. | 7 | $189 |
| Fresenius Kabi USA, LLC | 7 | $122 |
| Aurinia Pharma U.S., Inc. | 5 | $94 |
| Cumberland Pharmaceuticals, Inc. | 1 | $91 |
| Sanofi | 4 | $90 |
| Sobi, Inc | 3 | $85 |
| Bristol Myers Squibb | 4 | $75 |
| Organon | 4 | $71 |
| Sandoz | 3 | $58 |
| Mylan Institutional Inc. | 2 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
| Kyowa Kirin, Inc. | 2 | $45 |
| Mallinckrodt Enterprises LLC | 2 | $43 |
| Bioventus LLC | 2 | $37 |
| Pacira Pharmaceuticals Incorporated | 1 | $28 |
| Celltrion USA Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Janssen Scientific Affairs, LLC | 1 | $18 |
| Boehringer Ingelheim | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
How this compares
$11,648 in reported general payments places this provider in the 75th percentile of 159 rheumatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 106 | $4,600 |
| MethotrexateMethotrexate Sodium | 102 | $3,962 |
| Mycophenolate Mofetil | 24 | $3,952 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 137 | $3,739 |
| Pregabalin | 19 | $2,653 |
| Lidocaine | 12 | $2,462 |
| Hydroxychloroquine Sulfate | 80 | $2,061 |
| Tramadol Hcl | 185 | $1,903 |
| Gabapentin | 65 | $1,150 |
| Sulfasalazine | 17 | $981 |
| Diclofenac Sodium | 34 | $960 |
| Leflunomide | 25 | $896 |
| Prednisone | 171 | $770 |
| Etodolac | 12 | $653 |
| Cyclobenzaprine Hcl | 28 | $588 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Richmond
- Michael StrachanRichmond$158K
- Karim MasriRichmond$147K
- Tammy SpringRichmond$17K
- Mihail MoroianuRichmond$13K
- Bhakti JoshiRichmond$12K
- Avnit AhujaRichmond$12K
- Steven MaestrelloRichmond$9K
- Peter LipskyCharlottesville$1.3M
- Kristi MizelleNewport News$1.1M
- Phillip KempfArlington$321K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.